Vale W - Search Results

1

CRF receptors in the rodent and human cardiovascular systems: species differences.

Waser B, Rehmann R, Rivier J, Vale W, Reubi JC. Waser B, et al. Among authors: vale w. Peptides. 2006 Dec;27(12):3029-38. doi: 10.1016/j.peptides.2006.07.005. Epub 2006 Aug 21. Peptides. 2006. PMID: 16920225

2

Expression of CRF1 and CRF2 receptors in human cancers.

Reubi JC, Waser B, Vale W, Rivier J. Reubi JC, et al. Among authors: vale w. J Clin Endocrinol Metab. 2003 Jul;88(7):3312-20. doi: 10.1210/jc.2002-021853. J Clin Endocrinol Metab. 2003. PMID: 12843181

3

In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I.

Rivier C, Rivier J, Lederis K, Vale W. Rivier C, et al. Among authors: vale w. Regul Pept. 1983 Jan;5(2):139-43. doi: 10.1016/0167-0115(83)90121-0. Regul Pept. 1983. PMID: 6298906

4

Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists.

Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, DiGruccio M, Vaughan J, Reubi JC, Waser B, Koerber SC, Martinez V, Wang L, Taché Y, Vale W. Rivier J, et al. Among authors: vale w. J Med Chem. 2002 Oct 10;45(21):4737-47. doi: 10.1021/jm0202122. J Med Chem. 2002. PMID: 12361401

5

Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2.

Martínez V, Wang L, Rivier JE, Vale W, Taché Y. Martínez V, et al. Among authors: vale w. J Pharmacol Exp Ther. 2002 May;301(2):611-7. doi: 10.1124/jpet.301.2.611. J Pharmacol Exp Ther. 2002. PMID: 11961064

6

Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats.

Eaves M, Thatcher-Britton K, Rivier J, Vale W, Koob GF. Eaves M, et al. Among authors: vale w. Peptides. 1985 Sep-Oct;6(5):923-6. doi: 10.1016/0196-9781(85)90323-7. Peptides. 1985. PMID: 3878503

7

Pituitary somatostatin receptors: dissociation at the pituitary level of receptor affinity and biological activity for selective somatostatin analogs.

Reubi JC, Perrin M, Rivier J, Vale W. Reubi JC, et al. Among authors: vale w. Regul Pept. 1982 Aug;4(3):141-6. doi: 10.1016/0167-0115(82)90081-7. Regul Pept. 1982. PMID: 6127756

8

Comparison of the biologic actions of corticotropin-releasing factor and sauvagine.

Brown MR, Fisher LA, Spiess J, Rivier J, Rivier C, Vale W. Brown MR, et al. Among authors: vale w. Regul Pept. 1982 Jul;4(2):107-14. doi: 10.1016/0167-0115(82)90101-x. Regul Pept. 1982. PMID: 6289384

9

Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus.

Bloom FE, Battenberg EL, Rivier J, Vale W. Bloom FE, et al. Among authors: vale w. Regul Pept. 1982 Jun;4(1):43-8. doi: 10.1016/0167-0115(82)90107-0. Regul Pept. 1982. PMID: 6750704 No abstract available.

10

A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity.

Chen AM, Perrin MH, Digruccio MR, Vaughan JM, Brar BK, Arias CM, Lewis KA, Rivier JE, Sawchenko PE, Vale WW. Chen AM, et al. Among authors: vale ww. Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2620-5. doi: 10.1073/pnas.0409583102. Epub 2005 Feb 8. Proc Natl Acad Sci U S A. 2005. PMID: 15701705 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

921 results

Search Page

Filters